Workplace Transformation Market Players Witness New Opportunities with the Emergence of Covid-19

 

Workplace transformation is a buzzword for many corporate managers these days. This is because businesses have recognized the need to transform their business model in order to survive and succeed in the times of Covid-19. The pandemic has offered lucrative growth opportunities for players in the workplace transformation market.

Businesses have been scaling back costs by cutting expenses on marketing, distribution and service while relying more on online sales and automation. All this is going in the face of stagnant revenues as customers become jaded by high prices and dwindling profit margins. Workplace transformation market can thus benefit from initiatives to implement transformation efforts effectively. Transformational change can however, be impeded by the resistance from employees. Your efforts to increase productivity, save money and reduce costs may not be well received by your employees. Some will rebel against change while others may resist all forms of change. As a result, the transformation effort will go underway but it will be an uneven success.

Services offered in the workplace transformation market must focus helping employees understand the changes in an organization. For example, announce the plans at an event, hold training sessions so that employees know the new structure and function, give bonuses and pay raises if employees have successfully participated in the program. It is only when you share information about transformational programs with employees that they will begin to accept the changes you want to bring about in their workplaces.

Workplace transformation is a great business strategy because it drives profits and strengthens the company's ability to compete in today's market. These benefits drive growth of the workplace transformation market. When employees do accept change, they will feel more secure and productive. They will also appreciate being a part of something bigger than themselves. This increases the likelihood that they will embrace the workplace transformation you are imposing. The ultimate goal of workplace transformation is for employees to benefit from the transformation you are imposing on their workplace.

Players in the workplace transformation market are focused on adopting AI to drive significant efficiencies in workplace optimization. In this regard, Infosys recently announced to promote tools such as Nanoheal, Nexthink, SysTRack, and Infosys Nia to drive prognostic monitoring, self-heal, and self-service to drive efficiencies.

Seasoning Market is expanding rapidly with McCormick & Company, Inc., in partnership with Buzzfeed’s Tasty Platform, launching McCormick Tasty recipe mixes

 

Seasonings are the ingredients that bring out the taste of a dish. There is a large amount of variety and flavors of seasonings available to choose from. With changing lifestyles of people around the world, the demand for convenience food has increased significantly. In fact, the working women population is rising rapidly across the globe with growing urbanization, which is accelerating the demand for packaged food products. As per the Food and Drink Federation, the U.K., the food and drink manufacturing sector accounts for 17% in terms of economic contribution. As per the United Nations (UN), by 2050, around 68% of the global population is expected to live in urban areas, increasing from 55% in 2018. As a result of this demand for spices and seasonings is increasing, which could potentially stimulate growth of the seasoning market.

Herb seasonings are those that are usually included in cooking. Herb seasonings add freshness to the dish. Herbs such as basil, garlic, rosemary, and thyme are used all over the world for seasoning their cuisines. Consumers across the globe have become more aware of what they are buying and what they really want. The majority of consumers scrutinize every product they buy, in order to make sure they are purchasing the desired item only. As a result of this, the demand for the clean label has increased rapidly. The clean label refers to food products that have fewer and simpler ingredients. Hence, such factors can augment growth of the seasoning market.

Herbs are used to add flavor to our food. They are used in cuisines such as Indian, Chinese, Japanese, Middle Eastern, and many other cuisines. Rosemary, Thyme, Oregano, Parsley, and Sage are a few examples of herbs used for seasonings. However, there are certain challenges that are proving to be detrimental to the growth of the seasoning market. Concerns regarding adulteration in seasonings can be a major issue in the market. Besides, some spices and seasonings are prone to microbial contamination, which can potentially limit growth of the seasoning market.

Pickling seasonings are used for raw vegetable dishes to preserve the freshness of the vegetables. It is best to pickle the vegetables at room temperature for about a day. Consumers in Asia Pacific region use different types of spices and seasonings extensively in their daily meals. High consumption of seasonings is typically attributed to Asian cuisine to enhance the flavor of the food as well as for medicinal benefits, which could accelerate the regional seasoning market. On the contrary, the demand for seasoning is rising in North America since they are being widely used in dressings for salads and sauces.

Recently, in February 2019, McCormick & Company, Inc., in partnership with Buzzfeed’s Tasty Platform, launched McCormick Tasty recipe mixes.

QBE North America launched enhanced Organ Transplant (OT) product for global organ transplant market

 

North America is expected to lead the global organ transplant market and this is because this region accounted for the strong presence of the healthcare industry in the region. Also, the high burden of chronic disease in the region which is increasing the prevalence of organ failure is again projected to propel the regional market growth. According to National Health Council, generally incurable and ongoing, chronic diseases affect approximately 133 million Americans, representing more than 40% of the total population of this country.

The increasing incidence of organ failure around the globe is expanding the global organ transplant market size. Organ failure may occur due to various health conditions such as serious trauma, poisoning, loss of blood, drug abuse, sepsis, leukemia, and other acute diseases. According to The Regents of the University of California, nearly 750,000 patients per year in the United States and an estimated 2 million patients worldwide are affected by kidney failure. More than 100,000 patients in the United States are on the kidney transplant list. The growing geriatric population is increasing the prevalence of the chronic disease. This is further projected to augment the growth of the organ transplant market.

In September 2019, QBE North America, an integrated specialist insurer has announced the launch of an enhanced Organ Transplant (OT) product, designed to provide policyholders with nationwide access to transplant Centers of Excellence and Transplant Nurse Navigators
In September 2020, Natera, Inc. a provider of cell-free DNA, announced an expansive program to improve care for organ transplant patients with a history of cancer, using the Signatera™ test for molecular residual disease (MRD) assessment pre-and post-transplant, in combination with the Prospera™ test for transplant rejection assessment
In December 2020, (PTI) Drug firm Lupin announced the launch of Mycophenolate Mofetil tablets, used to help prevent the body from rejecting organ transplants, in the US.
Organ Transplant is a major medical procedure where an organ, usually a lung or a kidney, is taken out of one human body and put into the body of another human, to replace a missing or damaged organ. The donor and recipient can usually be in the same room, or organs can be transported between donor sites to another site. The lungs, stomach, liver, heart, intestines, and kidneys are the common transplant areas. The Spicer score is one of the most commonly used metrics in assessing whether a patient is a suitable candidate for an organ transplant.

Medical Vacuum System Market Growth Driven By Increasing Focus Reducing Risk of Airborne Transmission of Infectious Diseases

 

Increasing focus on creating new methods of active barrier protection using negative pressure to reduce the risk of airborne transmission of infectious diseases in hospitals and triage settings is expected to aid in growth of the medical vacuum system market. In April 2021, Scone Medical Solutions Inc., a medical device company, received the United States Patent and Trademark Office, which is directed to a system of creating a Self-Contained Negative Pressure Environment (SCONE) to remove airborne particulates from an environment.

Emergence of Covid-19 is also expected to aid in growth of the medical vacuum system market. Globally, as of 5:16pm CEST, 28 April 2021, there have been 148,329,348 confirmed cases of COVID-19, including 3,128,962 deaths, as reported to the World Health Organization.

Medical vacuums are widely used for the patient's medical care in various ways. Earlier, in the early of 1960s, healthcare services realized the hazards of the use of large, high-pressure cylinder of medical vacuums for patient care. In place of this, medical vacuums and other vacuum systems are now offered by medical vacuum's pipeline system (MTVS). The technology behind these devices is based on the principles of pressurized gas and air, which are capable of delivering high pressures to desired areas in the medical field. Therefore, this technology has made it a boon to various healthcare industries and technicians.

Adoption of medical vacuum in anesthetic gas delivery system is expected to aid in growth of the medical vacuum system market. There are various reasons why this vacuum pump is used as an anesthetic gas delivery system. It can be used in hospitals to manage patient fluid loss or excessive air flow. For this reason, the system can also be installed at the operating room for maintenance purposes. The anesthetic gases provided by the anesthetic air system are of low concentration and of a low dose. As per the size of the anesthetic gas delivery system, the pipes and fittings need to be installed properly. The length of the pipe needed depends on the amount of anesthetic gas delivered, while the diameter of the anesthetic tube depends on the diameter of the outlet pipe. Moreover, the length of the piping needed also depends on the amount of gas capacity needed to operate the anesthetic gas delivery system. Thus, the installation process takes time and sometimes may require professional help.

Players in the medical vacuum system market also offer accessory mechanisms such as expansion valves and inlet filters. These accessories help prevent backflow of contaminated air into the system. Backflow prevention is a major mechanism for preventing contamination in the anaerobic environments found around hospitals. All these accessories help maintain the quality of the product and extend its life span.

Excimer Laser Devices Market is gaining significant traction with Strata Skin Sciences receiving the U.S. FDA approval for its Xtrac Momentum excimer laser system

 

Excimer Laser Devices is extremely useful in medical practices. These are not the only laser devices out there but they are among the most commonly used. They are used in so many different ways that it is impossible to list them all in one article. However, here are some of the most important things that you might want to know about these lasers. Over the years, due to technological advancements, eye surgeries have become far more common than they were previously. Advanced devices such as excimer laser devices are commonly used in eye surgeries, typically corneal refractive surgery. As per the Eurostat, in 2018, around 1656 cataract surgeries per 100,000 inhabitants were performed in Latvia. Such high number of eye surgeries suggests growing acceptance of common people towards advanced laser devices. Thus, such factors can augment growth of the excimer laser devices market.

These lasers have been in existence for decades. However, not many doctors are using them because they haven't been approved for clinical use yet. They are still being developed and scientists continue to look at them. It is actually expected that within the next few years, laser surgery could be available to anyone who wanted it. Right now, the Food and Drug Administration has approved the use of lasers for cosmetic treatments. Continuous research and development activities in the field of excimer lasers have led to the development of many new advanced and innovative laser devices. As a matter of fact, modern excimer laser devices offer a unique combination of high pulse energy and short pulse duration in the UV lengths generated. Recently, in October 2018, Alcon, a subsidiary of Novartis, launched an enhanced WaveLight Refractive Suite to optimize patient and surgeon LASIK experience. Thus, such factors can stimulate growth of the excimer laser devices market.

Recently, in January 2020, Strata Skin Sciences received the U.S. Food and Drug Administration (FDA) approval for its Xtrac Momentum excimer laser system for treating a number of skin diseases.

As far as regional impact is concerned, developed countries such as the U.S. have exhibited high traction in the excimer laser devices market. With rising volume of surgical procedures, the demand for excimer laser devices is likely to accelerate rapidly in the region. Similarly, European countries such as the U.K. and Germany are witnessing high demand for excimer laser devices due to significant growth in the number of surgeries in European countries.

Today, these excimer laser devices are used for a variety of medical procedures. One of the most common uses today is to fade scars, tattoos, and birthmarks. Any type of skin problem can be treated successfully using these devices. Regardless, one of the biggest disadvantages of using an excimer laser is its limited lifespan. It is hindered by gas contamination, dust produced by electric discharge, corrosion processes, and other reasons. As a result of this, the device might be subjected to frequent maintenance and repair, which can impede growth of the excimer laser devices market.

Medela LLC has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ENFit Low Dose Tip enteral syringes market

 

Growing cases of critical care and neonatal intensive care unit admissions are propelling the growth of the global enteral syringe market. According to statistics given by Bliss Organization, over 95,000 newborns are admitted to neonatal units in the U.K, annually due to premature birth (before 37 weeks of pregnancy) or due to full term (after 37 weeks) yet sick birth. Moreover, according to the same source around 1 in every 8 newborns in the U.K are admitted to neonatal units, annually. The increasing geriatric population around the globe is again augmenting the growth of the market. According to the United Nation, the global population aged 60 years or over numbered 962 million in 2017, the number of older persons is expected to double again by 2050, when it is projected to reach nearly 2.1 billion.

North America is expected to dominate the global enteral syringe market and this is attributed to the continuous launch of the innovative product by key players in the region. For instance, in February 2017, Baxter International Inc. a global provider of nutrition therapy announced the expansion of its nutrition care portfolio to include the new enteral ENFit® syringe and accessory line for patients requiring tube feeding in the United States during the American Society of Parenteral and Enteral Nutrition’s (ASPEN) Clinical Nutrition Week (CNW) conference.

In March 2017, Medela LLC has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market ENFit Low Dose Tip enteral syringes. The ENFit Low Dose Tip can help to deliver accurate doses while reducing the risk of misconnections
In July 2017, Gerresheimer will complete its product portfolio of prefillable syringes made of glass and plastics with an innovative, integrated, passive syringe safety solution, acquired through an exclusive license from West Pharmaceutical Services, Inc.
In June 2019, NeoMed has launched NeoConnect at Home, a reusable portfolio of ENFit syringes that do not require a physician’s prescription.
Key players operating in the global enteral syringe market include GBUK Enteral Ltd., Thermo Fischer, Inc., B. Braun Melsungen AG, Koninklijke Philips N.V., Miktell Ltd., Baxter International, Inc., Cardinal Health, Inc., Terumo Corporation, Kentec Medical, Inc., Vygon S.A., and others.

Enteral Syringes are designed to deliver nutrition to the body quickly. The syringe contains two removable plastic tubes, one tube is inserted into the mouth of the patient. The tube then travels down the drainage path until it reaches the cannula which is used to administer the medication. The tubes are then inserted back into the mouth so that the medication can be delivered directly to the intestines.

The Dermatology EMR Software Market to Witness Robust Growth Due to Increasing Awareness Regarding EMRs in Healthcare Sector

 

Electronic medical records (EMRs) is a part of electronic health records (EHRs). EHR/EMR software is a computer system that helps healthcare providers manage patient medical records and automate clinical workflows. In dermatology, EMR software is used to document patients' medical histories. Dermatology is the branch of medicine dealing with the skin. With the help of dermatology EMR software, hospitals can record and track their patients' treatment and health. Dermatology outpatients include a large number of patients with chronic diseases because they require a longer follow-up period for the treatment. Thus, EMRs are useful in dermatology to record dermatological data.

The dermatology EMR software market growth can be attributed to the increasing prevalence of skin diseases, such as seborrheic dermatitis, hives, vitiligo, ichthyosis, rosacea, psoriasis, acne, and eczema around the world. According to the American Academy of Dermatology (AAD), acne is the most common skin condition in the United States, which affects around 50 million people each year. Acne usually begins in puberty and affects many adolescents and young adults. Thus, with the increasing prevalence, the demand for dermatology EMR software is also increasing rapidly, in turn is driving the dermatology EMR software market growth.

In December 2020, MedX Health Corporation announced the launch of DermSecure, MedX's skin screening telemedicine platform, across the Netherlands in partnership with the national telehealth leader The Netherlands Institute for Prevention and Health (IVPG), offering greater access to medical specialists during the COVID-19 crisis. IVPG plans to expand to 41 skin assessment clinics by 2022. Moreover, in June 2020, MedX Health signed an agreement with EMC LABS, operating as MedX Mexico, to launch an aggressive ease-of-access skin scanning or assessment program, using MedX’s SIAscopy on DermSecure Telemedicine platform. This, in turn is also expected to propel the dermatology EMR software market growth.

Furthermore, technological advancements in the EMR software and increasing adoption of EMR software with advanced features are some major factors driving the dermatology EMR software market growth. For instance, in 2018, Modernizing Medicine, Inc., launched EMR software at the American Academy of Dermatology (AAD) 2018 Summer Meeting. The new EMR software features the dermatology EHR system, including Inventory Management, Real-time Prescription Benefit, and Electronic Prior Authorization (ePA). However, increasing cost of EHR services is major factor restraining the dermatology EMR software market growth.

On the basis of region, the global dermatology EMR software market is segmented into North America, Asia Pacific, Europe, Latin America, the Middle East, and Africa.

Delivery Drones Market is booming at a fast pace with companies such as Amazon, Wingcopter, Zipline, Flytrex, and others getting approvals from ICAO and FAA to deliver packages using drones

 

A delivery drone is an autonomous unmanned aerial vehicle employed to deliver goods, medical supplies, food, and other goods. Delivery drones are generally autonomous, though some types require the user's permission to fly. In May 2021, the U.S. Federal Aviation Administration (FAA) presented two options to regulate the safe use of drones, one of which would establish a minimum safety standard for all types of delivery. The FAA granted Amazon the permission to use its Prime Air delivery drones to securely distribute deliveries to customers in August 2020.

The demand for delivery drones has significantly increased in the healthcare sector and the food & beverage sector since the outbreak of COVID-19 pandemic. DGCA (Directorate General of Civil Aviation), the national regulator of aviation in India, had approved the fleet of drones and jets of the Boeing Company in April 2021.

Drone delivery has been used in several instances as a substitute for more traditional aerial deliveries. It enables shorter delivery times, saving energy and money. Delivery Drones have also been used to make short, time-sensitive deliveries to homes and businesses, such as picking up flowers and food from the home, placing products on store shelves, and delivering parcels to people's front door. These deliveries are usually made within a 30 minute window, which makes these deliveries ideal for running a business out of one's home.

The delivery drones market has received much interest due to increasing demand for instant delivery services around the globe, provision of medical drugs at remote locations, and non-contact type delivery alternatives to avoid spread of contagious diseases such as COVID-19 infection. Although, customer adoption is a major restraint and sensitivity of drones are some of the factors that are limiting the market growth. Furthermore, stringent regulations associated with air traffic administration for delivery drones are poised to stifle growth of the delivery drones market.

Due to growing adoption of drones for commercial purpose in the region, North America is witnessing a considerable surge in the delivery drones market. The demand for the delivery drones market is likely to expand as the adoption of delivery drones increases in the military and defense sector for intelligence and surveillance purpose. Likewise, the integration of the AI (Artificial Intelligence) in drones for several applications in multiple sectors is projected to pave a way of growth opportunities for the companies operating in the delivery drones market.

Vitreous Tamponades Market Growth Driven by High Incidence of Diabetic Retinopathy across the Globe

 

Vitreous tamponades are used to provide surface tension across retinal breaks, which prevents further fluid flow into the subretinal space until the retinopexy provides a permanent seal. Gases and silicone oils are the most commonly used classes of tamponade agents. Silicone oils are permanent and remain in the eye until surgically removed.

High prevalence of various retinal diseases is expected to propel growth of the vitreous tamponades market. According to the study ‘Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis’, published in the journal Lancet, in 2015, 2.6 million people were visually impaired because of diabetic retinopathy, and the number is expected to reach 3.2 million in 2020.

Prevalence of diabetes plays a major role in risk of diabetic retinopathy According to the study, “Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition”, published in the journal Diabetes Research and Clinical Practice, in September 2019, 463 million people are expected to suffer from diabetes in 2019 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045.

Vitreous tamponades are used in the treatment of retinal detachment. The most common gas tamponades used in the U.S. are air, SF6, and perfluoropropane (C3F8). In the U.S., the number of people in the U.S. suffering from diabetic retinopathy is expected to reach 14.6 million in 2050 from 7.7 million in 2010, according to the Centers for Disease Control and Prevention. Such scenario is expected to aid in growth of the vitreous tamponades market.

Use of vitreous tamponades is associated with several important complications such as chronic postoperative elevated intraocular pressure and hypotony. Other complications include, corneal edema, corneal opacity, or need for corneal transplant. Moreover, silicone oils and gases provide less effective tamponade for cases with inferior retinal breaks and conventional silicone oils are relatively less effective in the treatment of inferior retinal detachment. Such side effects are expected to hinder growth of the vitreous tamponades market.

Geriatric population is prone to various retinal diseases. According to United Nations Population Fund, geriatric population in Asia Pacific is expected to triple between 2010 and 2050 to reach 1.3 billion people by 2050. Asia Pacific is thus expected to witness significant growth in the vitreous tamponades market.

Self-Reconfiguring Modular Robot Market is gaining massive traction with German robots manufacturer KUKA AG launching KR QUANTEC series for automotive and foundry sectors

 

Self-Reconfiguring modular robots or remotely self-reconfiguring modular robots are fully autonomous mechanical machines with variable shapes. These machines have the ability to reconfigure themselves and thereby make use of different configurations available on their onboard software. In terms of regions, North America has emerged as the most demanding region in the self-reconfiguring modular robot market. This is due to the fact that there is a high investment in tech startups and robots are witnessing high demand in both civil and military institutions. That being said, these robots require high capital investment for installing, even it is for low-volume production. Therefore, medium and small-sized businesses find it difficult in adopting such robotic solutions, which could potentially limit growth of the self-reconfiguring modular robot market in the near future.

Recently, in January 2019, KUKA AG, a German industrial robots manufacturer, launched a new generation of the KR QUANTEC series, typically designed for the use in the automotive industry, medicine, and foundry.

These self-reconfiguring modular robots can be used in industrial, manufacturing, service, and construction activities. Furthermore, they have applications in the human field also. Self-reconfiguring modular robots have witnessed high demand from various end-use industries including electronics, automotive, and rubber & plastic industry. These end-use industries have witnessed robust growth over the years in both developed and emerging economies. According to the India Brand Equity Foundation (IBEF), India’s domestic automobile sales reached 21.55 million units in FY20, registering a CAGR of 1.29%. Furthermore, as per the Organisation Internationale des Constructeurs d'Automobiles (OICA), commercial vehicle sales reached 27 million units in 2019, increasing from 20 million units in 2011 globally. These robots play an essential role in the automotive sector to perform repetitive activities such as disassemble and reassemble machines. Hence, such factors can stimulate growth of the self-reconfiguring modular robot market.

Modular robots have a flexible hardware architecture and a system of self-contained motor and software that allows their operators to make the necessary changes as and when required. The robots come with a software package that facilitates its easy configuration. The configuration software guides the operator about the steps to be taken in order to change the functionality of the machine. The changes made in the configuration software are not permanent but are reversible, hence the name 'modular'. These robots have found to be significantly versatile and robust in nature. Therefore, the adoption of these robots has increased to a greater extent for economic scalability. Furthermore, intricate projects such as space exploration require intelligent robots, where self-reconfiguring modular robots have emerged as the perfect solutions. Thus, such advantages can augment growth of the self-reconfiguring modular robot market in the near future.

WHO Member States have agreed to reduce the global population’s intake of salt by a relative 30% by 2025 fueling growth of the salt substitutes market

 

Rapid urbanization and sedentary lifestyle have increased the intake of salt among consumers and this has raised the prevalence of obesity and ultimately progression of other diseases. For instance, consumption of food that is high in salt content caused high blood pressure. Thus the high prevalence of lifestyle-related disorders is propelling the growth of the salt substitutes market. According to the World Health Organization, in 2019, an estimated 38.2 million children under the age of 5 years were overweight or obese. Once considered a high-income country problem, overweight and obesity are now on the rise in low- and middle-income countries, particularly in urban settings.

Major Developments:

In November 2019, The U.K. supermarket chain Tesco has started stocking ground seaweed products for consumers wanting to reduce their sodium intake and add umami flavors to their food. It is a natural salt replacement that is being sold under the Mara Seaweed brand and is sourced from Scotland.
In January 2018, Commodity trader Cargill Inc. has started to produce a salt-alternative for food manufacturers wanting to cut back the sodium levels in their soups, bread, and other processed goods.
The Asia Pacific is expected to dominate the global salt substitutes market in the near future and this is attributed to the increasing adoption of a healthy lifestyle among consumers across countries such as China, South Korea, and India. Rising awareness regarding the benefits of cutting down salt intake in the diet is again augmenting the regional market growth.

Moreover, WHO Member States have agreed to reduce the global population’s intake of salt by a relative 30% by 2025. An estimated 2.5 million deaths could be prevented each year if global salt consumption were reduced to the recommended level. For instance, world Health Organization recommends that adults consume less than 5 g (just under a teaspoon) of salt per day.

Salt substitutes are basically low-salt, artificial sweeteners sold in place of regular table salt to circumvent the potential danger of heart disease and high blood pressure brought about by high consumption of regular table salt. These substances are made by extracting sodium from common salt - either kosher or regular - and making it into a concentrated salt solution, which can then be used for cooking or baking. Most commercially produced salt substitutes contain no more than 2 percent sodium, which is well below the current maximum daily intake recommended for adults of all ages. They are also generally recognized as healthier alternatives to regular table salt because they do not contain any animal fat, which tends to raise blood pressure levels and is unhealthy on its own.

Because of the emergence of COVID-19, the tissue towel market has been steadily increasing

 

A tissue towel, or tissue paper towel, refers to paper towel which is an absorbent towel made from tissues. A tissue towel is disposable, soft, light weight, and can be used only once. The towel has good strength and absorbency. A tissue towel offers many advantages such as prevention of bacterial infection, which reduces the risk of communicable diseases such as cold and flu. Tissue towels are widely used in households, as kitchen towel, kitchen rolls, and other varieties. According to the Centers for Disease Control and Prevention (CDC), in 2018, around 9,025 cases of TB (tuberculosis), around 60,999 cases of salmonella, around 33,666 cases of Lyme disease, and 327 cases of meningococcal disease were reported in the United States.

The above mentioned factors are driving the tissue towel market growth. Thus, with increasing prevalence of communicable diseases, demand for tissue towel is also increasing. According to the Ocean Conservancy, each year, around 13 billion pounds of paper towels are used in the U.S. This is equivalent to 40 pounds or 80 rolls per person per year. Growth of the tissue towel market is also driven by the emergence of COVID-19 (SARS-CoV-2). Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. According to the World Health Organization (WHO), worldwide as of 2:27pm CET, 21 March 2021, there have been 122,524,424 confirmed cases of COVID-19, including 2,703,620 deaths.

Moreover, the tissue towel market is witnessing significant growth owing to increasing demand for paper towels and increasing awareness among people about health and hygiene. Thus, market players are focused on launching new and innovative products to meet increasing demand and to strengthen their product portfolio. For instance, in May 2020, Sofidel launched new Nicky Defend, a disposable tissue paper towel with antibacterial lotion designed for the Consumer market and specifically developed to guarantee proper hygiene. Moreover, in April 2020, the company launched new Regina Pets paper towel designed for pet owners caring for their furry friends. Regina Pets is the alternative to a fabric towel or kitchen roll.

Furthermore, increasing utilization of tissue towels, change in consumer lifestyle, expansion of hospitality industry, rapid urbanization, and surge in disposable income positively affect the tissue towel market. Likewise, rising health consciousness and the cost-effectiveness extend profitable opportunities to the tissue towel market. However, environmental concerns are restraining the tissue towel market growth. Thus, several manufacturers, especially in the U.S., are using recycled papers to minimize environmental pollution.

Increased prevalence of chronic diseases and the introduction of non-opioid drugs are expected to boost the pain management drugs market

 

Pain management, pain therapy, and pain suppression or manage pain, is a broad branch of medical science which makes use of an interdisciplinary approach in order to ease the physical suffering and enhancing the quality of life of the individuals living with debilitating chronic pain. The pain management includes evaluating, diagnosing, treating, and preventing painful disorders and conditions by providing comprehensive pain management services. The main types of medications used for pain management are analgesics, antidepressants, narcotics, and sedatives.

Market Dynamics

Increasing prevalence of chronic diseases is expected to propel growth of the pain management drugs market. For instance, according to the Centers for Disease Control and Prevention (CDC)’s May 2019 report, an estimated 54.4 million US adults have diagnosed arthritis, which accounted for around 1 in 4 people in the U.S.

Launch of non-opioid drugs is expected to offer lucrative growth opportunities for players in the pain management drugs market. For instance, in November 2019, Q Biomed Inc. announced the U.S. FDA approval of its contract manufacturer IsoTherapeutics Group LLC (ITG) to manufacture the company's Strontium-89 Chloride USP, a non-opioid radiopharmaceutical indicated for the treatment of painful skeletal metastases caused by cancer.

Prescription drug abuse is expected to hinder growth of the pain management drugs market. For instance, according to the study, ‘ The Future of Fentanyl and Other Synthetic Opioids,’ published by RAND Corporation in 2019, the number of deaths involving synthetic opioids increased from 3,000 in 2013 to more than 30,000 in 2018, in the U.S.

Among regions, North America is expected to witness significant growth in the pain management drugs market, owing to increasing prevalence of cancer in the region. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.

Competitive Analysis

Major players operating in the pain management drugs market include, Pfizer, Inc., Sanofi S.A., Mylan N.V., Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Abbott Laboratories, Purdue Pharma L.P., Q Biomed Inc., Lupin Ltd., Bicon Ltd., GlaxoSmithKline Plc, Johnson & Johnson, and F. Hoffmann La Roche Ltd.

Major players operating in the pain management drugs market are focused on launching new products to expand their product portfolio. For instance, in December 2020, Bicon Ltd. launched Tacrolimus, an immunosuppressant used in organ transplant patients to reduce the body’s ability to reject a transplanted organ. Similarly, Lupin Ltd. launched Meloxicam capsules in 5 mg and 10 mg dosages, used for management of osteoarthritis pain, in the U.S.

As key marketer Sanofi reports clinically relevant changes for its Phase III trial of Enzyme Replacement Therapy, the Pompe Disease Therapeutic market is expected to grow significantly

 

Pompe disease or additionally alluded to as Glycogen stockpiling sickness type II is an autosomal passive metabolic problem that harms nerve cells and muscles all through the body. It is normally caused because of the aggregation of glycogen in the lysosome, inferable from insufficiency of the lysosomal corrosive alpha-glucosidase chemical.

Rising commonness of Pompe sickness is relied upon to drive development of the worldwide Pompe disease therapeutic market during the estimate time frame. As per the National Organization for Rare Disorders (NORD), around 1 out of 40,000 births in the U.S. what's more, the Netherlands are influenced with Pompe illness. As indicated by a similar source, a new report showed that the province of Missouri revealed a higher pervasiveness of 1 out of 5,463. Pompe illness can happen in different populaces and ethnic gatherings across the globe. As indicated by the Pompe Disease News, around 5,000 to 10,000 individuals have Pompe illnesses around the world. Thus, the interest for new restorative treatment alternatives is expanding internationally. In this way, these components are relied upon to drive development of the worldwide Pompe illness helpful market during the figure time frame. Moreover, proactive drives taken by government specialists to create and make inventive items for the conclusion and treatment of uncommon illnesses are required to impel the worldwide Pompe disease therapeutic market development over the estimate time frame.

However, the high cost associated with treatment is expected to hinder the global Pompe disease therapeutic market growth over the forecast period. Continuous research and development activities can present lucrative growth opportunities in the global Pompe disease therapeutic market in the near future. Among regions, North America is expected to witness significant growth in the global Pompe disease therapeutic market during the forecast period. This is owing to the presence of robust healthcare infrastructure across the region. Furthermore, Europe is expected to register a robust growth rate over the forecast period, owing to continuous research and development activities combined with proactive support from government authorities to improve the healthcare sector.

Key companies operating in the global Pompe disease therapeutic market are CENTOGENE AG, Amicus Therapeutics, Inc., AVROBIO, Inc., Sanofi, Valerion Therapeutics, Audentes Therapeutics, and Oxyrane.

For instance, in June 2020, Sanofi announced results of Phase III trial for its investigational enzyme replacement therapy (ERT) avalglucosidase alfa indicated for late-onset Pompe disease (LOPD) with clinically meaningful improvement.

Royal Philips launching a remote patient obstetrics monitoring suite to assist clinicians and expectant mothers during the COVID-19 pandemic, the Intrapartum Monitoring Devices Market is booming

 

Intrapartum Monitoring devices are a new generation of fetal monitor devices that utilize ultrasound technology to deliver continuous monitoring during labor. These highly advanced monitors do not require patients to remain in the delivery room and can easily be attached to the mother's belly just before her labor begins. The device has a probe resembling a harmless camera that is inserted into the uterus via the birth canal. As the fetus grows and stimulates contractions, the ultrasound transducer produces a picture of the developing baby and the doctor can view it on the screen. Intrapartum monitoring devices are typically useful during preterm. These devices are critical in assessing the well-being of a fetus during the labor and delivery process. Such devices can play a key role in controlling infant mortality. As per the World Health Organization (WHO), February 2018, around 15 million babies are born preterm i.e. before 37 completed weeks of gestation every year. As per the Centers for Disease Control and Prevention (CDC), around 21,000 infants died in the U.S. in 2018. Hence, such factors can contribute to growth of the intrapartum monitoring devices market.

Intrapartum monitoring devices have revolutionized the way that mothers are monitored during labor. These new technologies provide a high level of accuracy that was previously impossible. The picture produced is often clearer than what would be possible with older monitoring methods and there are no recordings necessary to keep track of vital signs. Over the years, the demand for maternity care devices has increased rapidly, in both developed and emerging economies. Devices such as baby scale, fetal stethoscope, infant stethoscope, and suction apparatus are critical in evaluating the health of infant babies. Thus, such factors are augmenting growth of the intrapartum monitoring devices market.

Despite its numerous advantages, there are some major issues associated with accessibility and affordability, which remain a major challenge in the adoption of intrapartum monitoring devices. Furthermore, there are stringent regulatory policies imposed by government authorizes, which could hinder growth of the intrapartum monitoring devices market in the near future.

Recently, in June 2020, Royal Philips launched a remote patient obstetrics monitoring suite to support clinicians and expectant mothers during the COVID-19 pandemic

Doctors and nurses are just beginning to discover the many ways that Intrapartum Monitoring can benefit their patients. In the case of drug withdrawal symptoms, for instance, if a mother monitors her child's drug withdrawal symptoms before it begins, doctors can intervene earlier and provide treatment. When it comes to countries, the U.S. is exhibiting promising signs in the intrapartum monitoring devices market. This is due to the fact that there is a high preterm birth rate in the country. Furthermore, the adoption of ongoing technological advancements can augment regional market growth in the near future.

With ROMEG Therapeutics receiving FDA approval for its GLOPERBA (colchicine) Oral Solution, 0.6 mg/5 mL for Prophylaxis of Gout Flares in Adults, the Gouty Arthritis Market is gaining significant traction

 

Gouty arthritis is a kind of joint inflammation that causes aggravation, normally in one joint, which starts unexpectedly. Gouty joint inflammation is brought about by the statement of needle-molded precious stones of uric corrosive in a joint. The essential manifestations of gouty joint inflammation incorporate serious agony, expanding, and redness in joints, frequently in the enormous toe.

Expanding pervasiveness of gout with rising liquor utilization is required to drive development of the worldwide gouty arthritis market. As per the Centers for Disease Control and Prevention (CDC), from 2013-2015 around 54.4 million grown-ups in the U.S. have some type of joint pain, gout, rheumatoid joint pain, or fibromyalgia. As per the Arthritis Foundation, 8 million individuals in the U.S. experience the ill effects of gout joint inflammation consistently. As per a similar source, high admission of sweet or cocktails is one of the significant danger factors for gout joint pain. Liquor is a significant wellspring of purine, which produces uric corrosive. Significant degrees of uric acids in the body can bring about the development of gems of uric corrosive, at last prompting gout. Thus, such factors are required to drugs market is relied upon to drive development of the worldwide Gouty arthritis market. Moreover, expanding appropriation of biologics and expanding R&D exercises in regenerative drugs is required to impel the worldwide Gouty arthritis market development sooner rather than later.

Side-effects associated with therapeutics drugs and high indirect costs of gout therapeutics are expected to hamper the global gouty arthritis market growth in the near future. Besides, lack of awareness among the medical fraternity regarding effective treatment of the condition, typically in emerging economies is expected to restrain growth of the market. Among regions, North America is expected to witness significant growth in the global gouty arthritis market. This is owing to high prevalence of gouty arthritis in the U.S. According to the clinical guidelines for gout published in Annals of Internal Medicine, in 2017, around 3.9% of U.S. adults aged 20 years and above reported gout at least once in a lifetime. Furthermore, Asia Pacific is expected to register a robust growth rate, owing to rising number of patients suffering from chronic diseases such as cardiovascular disease across the region.

Key companies involved in the global gouty arthritis market are Lannett Company, Inc., Teijin Pharma Ltd, Boehringer Ingelheim, Takeda Pharmaceutical Company Ltd, GlaxoSmithKline plc, ROMEG Therapeutics, LLC, Horizon Therapeutics plc, Regeneron Pharmaceuticals, Mylan NV, Merck& Co. Inc., and Novartis International AG.

For instance, in February 2019, ROMEG Therapeutics, LLC received the U.S. Food and Drug Administration (FDA) approval for its GLOPERBA (colchicine) Oral Solution, 0.6 mg/5 mL for prophylaxis of gout flares in adults.

The high prevalence of chronic kidney disease in North America, the chronic kidney disease drugs market is expected to rise

 

Chronic Kidney Disease is an ailment related with debilitate of kidney work and the danger of kidney disappointment, typically in blend with various kidney infections including renal colic, and end stage renal illness, intense cylindrical putrefaction. Kidney disappointment happens because of one or the other essential or auxiliary harm to the kidneys from the development of scar tissue (plaque) due to scarring brought about by a kidney stone or different stores. Kidney stones are brought about by the development of uric corrosive gems inside the kidneys. There are various medications that can be utilized for the treatment of this sickness. One of these medications is called calcium channel blockers, which block the calcium directs in the kidneys.

The developing predominance of chronic kidney disease drugs all throughout the planet is a superb factor driving business sector development. As indicated by the National Kidney Foundation Inc., it influences an expected 37 million individuals in the U.S. (15% of the grown-up populace; more than 1 out of 7 grown-ups) and around 90% of those with CKD don't realize they have it. In 2017, more than 500,000 patients got dialysis treatment, and more than 200,000 lived with a kidney relocate. Additionally, the developing occurrence of diabetes is likewise projected to encourage market development. Besides, an ascent in worldwide medical care consumption combined with the increment in the geriatric populace as they are exceptionally inclined to such constant illness is additionally expected to cultivate the development of the chronic kidney disease drugs market.

The growing prevalence of chronic kidney disease drugs around the globe is a prime factor driving market growth. According to the National Kidney Foundation Inc., it affects an estimated 37 million people in the U.S. (15% of the adult population; more than 1 in 7 adults) and around 90% of those with CKD don’t even know they have it. In 2017, over 500,000 patients received dialysis treatment, and over 200,000 lived with a kidney transplant. Moreover, the growing incidence of diabetes is also projected to foster market growth. Furthermore, a rise in global healthcare expenditure coupled with the increase in the geriatric population as they are highly prone to such chronic disease is further expected to foster the growth of the chronic kidney disease drugs market.

North America is expected to gain significant growth over the forecast period and this is attributed to increasing medicare cost for treating chronic kidney disease in the region. According to the Centers for Disease Control and Prevention, overall Medicare costs for people with CKD were over $84 billion in 2017 or more than $22,000 per person.

Key Developments:

1. In August 2020, AstraZeneca India a science-led biopharmaceutical company announced the results from the clinical trials of its latest diabetes drug, dapagliflozin, showing significant benefits in reducing chronic kidney disease (CKD) progression in patients with and without type-2 diabetes.

2. In September 2019, The Janssen Pharmaceutical Companies of Johnson & Johnson announced that its drug INVOKANA® (Canagliflozin) has been approved by the U.S. Food and Drug Administration (FDA). This drug is beneficial in reducing the risk of end-stage kidney disease (ESKD) and cardiovascular events in patients with Type 2 diabetes and chronic kidney disease (CKD).

Chloroacetic Acid Market Growth to be Boosted by Increasing Demand from End-Use Industries

 

Chloroacetic acid (otherwise called monochloroacetic corrosive) is an organochlorine compound and a valuable structure block in natural union. It is a halogenated subsidiary of acidic corrosive which is utilized in assembling different synthetic mixtures, drugs, pesticides, penetrating liquids, and colors. Also, it is utilized to deliver or plan modern synthetic substances and is utilized as a compound moderate or thickening specialist in carboxymethyl starch and carboxymethyl-cellulose. Chloroacetic acid is utilized as an acidic subsidiary like amide, anhydride, hydrazide, ester, acyl chloride, and salt because of its high reactivity.

Expanding interest for chloroacetic acid in the farming business is driving the chloroacetic acid market development. It is a boring, translucent strong and is profoundly solvent in water. In the agribusiness business, carboxymethylcellulose is broadly utilized in the creation of showers and pesticides. Besides, the fast development of the farming business in China, India, and Brazil because of positive unofficial laws combined with crude material access is required to build the interest for pesticides, driving the chloroacetic acid market development. Moreover, the European Commission and the Environmental Protection Agency (EPA) have illustrated administrative standards pointed toward lessening unstable natural mixtures discharges, which is required to build the interest for bio-based synthetic substances.

These regulatory norms are expected to hamper the growth of the chloroacetic acid market. For example, manufacturers of chloroacetic acid have been fined as it is polluting the environment and is toxic, according to the European Chemicals Agency. One of the key reasons behind the growth of the market is the widespread usage of chloroacetic acid across end-use industries such as agriculture, cosmetics, chemical, and pharmaceutical. Moreover, due to the increasing global population, the demand for agrochemicals is increasing and this is increasing the demand for food grains, due to which the demand for chloroacetic acid is also expected to increase in near future.

In terms of geography, the chloroacetic acid market is divided into six regions, such as North America, Europe, Asia Pacific, South America, the Middle East, and Africa. In 2017, North America held the third-largest share in the market, owing to increasing demand for chloroacetic acid from end-use industries such as agriculture, cosmetics, chemical, and pharmaceutical. Asia Pacific is also expected to witness substantial growth in the market due to the rising agricultural industry in China and India amid regulatory inclination to increase production output at the domestic level. For instance, the Indian government introduced the Draft National Chemical Policy aimed at increasing chemical output at the domestic level from 3% to 6% by 2020.

Rising Fertilizer Supply in the Agriculture Sector to Drive Global Ammonia Market Growth

 

Ammonia is a harmful substance of high nitrogen and oxygen. For the most part, alkali is found as a bland, unscented gas with a sharp smell. It brings about various natural capacities like eliminating microscopic organisms and slaughtering microbial cells. Alkali has numerous applications both at the modern and family level. It is utilized as a starter for making manures, executing creatures during soil remediation and as a compost for domesticated animals takes care of. Ammonia is for the most part a dismal gas with an impactful scent. It radiates an incredible smell which is liable for the trademark sharp scent of the compound.

Market Dynamics

Increasing supply of fertilizers in the agriculture sector is expected to propel growth of the global ammonia market. For instance, according to The Food and Agriculture Organization of the United Nations, world supply of ammonia increased from 153,766 thousand tons in 2015 to 171,433 thousand tons in 2018. Moreover, increasing adoption of green ammonia fuel is also expected to aid in growth of the market. For instance, in June 2019, TFX International, a provider of vehicle transport in North America, announced to provide two diesel fuelled generators and transport trucks to use Hydrofuel ammonia fuel and Ammonia Solutions multi-fuels systems at the 1st National Hydrogen Mobility Innovation Conference in Mississauga, Ontario.

Significant developments in floating ammonia production is expected to offer lucrative growth opportunities for players in the global ammonia market. For instance, in November 2020, Golar LNG Limited agreed with Black & Veatch Corporation to expand on their long-standing FLNG relationship and enter into a collaboration agreement in the field of floating ammonia production, carbon capture, green LNG and hydrogen. Moreover, initiatives to boost adoption of ammonia in thermal power generation is also expected to aid in growth of the ammonia market. For instance, in December 2020, Japan announced to introduce ammonia into the fuel mix for thermal power generation as well as for shipping from the late 2020s as part of its efforts to achieve carbon neutrality in 2050.

Competitive Analysis

Major players operating in the global ammonia market include, Yara International ASA, BASF SE, CF Industries Holdings, Inc., Nutrien Ltd., Potash Corporation of Saskatchewan Inc., Dangyang Huaqiang Chemical Co., Ltd., Shanxi Jinfeng Coal Chemical Co Ltd., GTS Chemical Holdings plc., Togliattiazot, OCI Nitrogen B.V., Agrium Inc., Sabic, and Koch Fertilizer, LLC among others.

December 2020: Yara International ASA announced plans for 500,000 tons per annum green ammonia production in Norway, powering emission-free shipping fuels and decarbonized food solutions.

Approval and launch of new products, as well as an increase in the prevalence of eye diseases, are expected to boost the eyewear market's growth

 

Eyewear is made out of various embellishments and things worn either above or beneath the eyes, planned principally for ornamentation or style, assurance from the climate, and just to upgrade or improve visual keenness. It could be as covers, groups, or some other headgear. They are accessible in a wide assortment of tones and styles, with a wide scope of materials. For instance, you will find that on the off chance that you need to look cool and elegant at a dance club or in a stylish metropolitan design store, at that point the most reasonable eyewear for you are those with out of control, exceptional, and eye-getting plans.

Remedy eyeglasses, contact focal points, and wellbeing glasses have all been planned with one basic factor - to offer most extreme insurance from eye wounds and harm. There are loads of decisions with regards to picking the correct sort of eyewear. For instance, there are bifocals, spectacles, reformists, and pretty much some other plan you can consider.

Market Dynamics

Approval and launch of new products is expected to propel growth of global eyewear market over the forecast period. For instance, in November 2019, CooperVision received U.S. Food and Drug Administration (FDA) approval for its MiSight 1 day contact lens that is indicated to slow the progression of myopia in children 8-12 years old. Moreover, increasing geriatric population is also expected to boost demand for contact lenses. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.

Increasing prevalence of eye diseases is expected to offer lucrative growth opportunities for players in the global eyewear market. For instance, according to National Eye Institute’s projections, the number of people in the U.S. with cataract is expected to reach 50 million in 2050. Moreover, increasing awareness about vision care is also expected to aid in growth of the market. For instance, in February 2020, Essilor Vision Foundation, through its Vote for Vision campaign, encouraged the populace to get an eye exam in 2020.

Competitive Analysis

Key players operating in global eyewear market include, Luxottica Group SpA, Essilor International S.A, Carl Zeiss AG, Hoya Corporation (Life Care), Johnson & Johnson Vision Care, Inc., Cooper Companies Inc., Fielmann AG., Safilo Group Spa, Marcolin S.p.A., De Rigo S.p.A.

Major players in the global eyewear market are focused on launching various services to enhance their market share. For instance, in August 2020, Johnson & Johnson Vision released resources to enhance the contact lens experience in terms of comfort, safety and accessibility.

The Radiofrequency ablation devices market is rapidly growing, thanks to Boston Scientific Corporation's launch of DIRECTSENSE technology to monitor the effects of ablation procedures.

 

Radiofrequency ablation is a moderately new strategy for diminishing agony related with back torment. In a new audit distributed by an association that reviews clinical developments, the Global Commission on Systemic Palliative Care (GCSPC) expressed that the most well-known application for radiofrequency removal is the treatment of torment in the spine, which has been utilized since the 1970s. There are numerous different applications, albeit these are two instances of the commonplace kind of agony that this gadget is utilized to mitigate.

Rising prevalence of cancer is expected to drive growth of the global radiofrequency ablation devices market during the forecast period. The number of cancer cases has increased over the years globally. According to the World Health Organization (WHO), in 2018, around 18.1 million new cases of cancer and 9.6 million deaths due to cancer were reported globally. According to the same source, around 70% of deaths from cancer occur in emerging economies with lung cancer accounting for the majority of deaths followed by breast cancer. Furthermore, according to the National Cancer Institute, in 2020, around 1,806,590 new cases of cancer are expected to be diagnosed in the U.S. with over 600,000 people dying from this disease. Such high incidence of cancer has led to increased demand for radiofrequency ablation devices. Hence, these factors are expected to drive growth global radiofrequency ablation device market during the forecast period. Furthermore, rising prevalence of cardiovascular disease combined with increasing number of ablation procedures is expected to boost the global radiofrequency ablation device market growth over the forecast period.

Pyrethroids' Effectiveness in Controlling the Spread of the Invasive Malaria Mosquito to Boost Pyrethroids Market Growth

 

A pyrethroid, otherwise known as a pyrethrum, is an artificial organic compound derived from the flowers of pyrethroids. These are generally used in pest control and as household and commercial insecticides for use in gardens, fields and forests. There are other names by which pyrethrons are known such as pyrethrin, pyrethroid, pyrethrum, pyroxylenol and others.

Pyrethrons are derived from the oils extracted from pyrethroids. The word pyrethroid was first used in 1891 when Thomas O'Rourke, a British researcher first used pyrethroids, which is derived from the oil of pyrethrum, to describe the oil secreted by the flower of the same name. The essential oil is then applied to various plants, insects and other organisms as an insecticide. It is believed to be an effective insecticide against a wide range of pests such as leafhoppers, lacewings, dragonflies and flies.

Market Dynamics

Effectiveness of pyrethroids in controlling the spread of invasive malaria mosquito is expected to propel growth of the global pyrethroids market. For instance, in November 2018, researchers from Liverpool School of Tropical Medicine confirmed that using pyrethroid-PBO treated nets to prevent malaria is more effective at killing mosquitoes in areas where there is a high level of resistance to pyrethroids.

Increasing cabbage stem flea beetle resistance to pyrethoids and the negative impact of these insecticides on natural insect predators of the pest is expected to hinder growth of the global pyrethroids market.

Moreover, human exposure to pyrethroids has been linked to heart disease, which is also expected to limit the market growth. For instance, in January 2020, researchers from Columbia University, New York, in an invited Commentary published in JAMA Internal Medicine, reported that Pyrethroid, the insecticide generally regarded as posing low health risks to humans in ordinary exposure situations, may lead to a 50 percent increase in total mortality and three-fold increase in heart disease deaths in persons with high urinary levels of 3-PBA, a metabolic product of pyrethroids indicative of human exposure.

Pyrethroids market in North America is witnessing several regulatory changes. For instance, in October 2020, United States Environmental Protection Agency released several interim registration decisions for 13 pyrethroid insecticides and one herbicide, paraquat.

Competitive Analysis

Major players operating in the global pyrethroids market include, BASF S.E., Bayer Cropscience AG, FMC Corporation, DowDuPont, Monsanto Company, Nufarm, SinoHarvest Corporation, Syngenta A.G., Sumitomo Chemical, and United Phosphorus.

Pulmonary Drugs Market: New Empirical Research Report | Global Industry Analysis, Recent Developments, Opportunities, and Forecast (2021 – 2027)

 

Chronic obstructive pulmonary disease (COPD) or also known as chronic obstructive respiratory disease is a progressive condition wherein the airways become swollen, inflamed, and clogged due to the buildup of mucus. This mucus becomes the first line of defense against any irritant which leads to difficulty in breathing, coughing, chest pain, wheezing, and shortness of breath. With time, this mucous thickens and makes it difficult for the air to pass through.

Increasing incidence of respiratory diseases is expected to drive growth of the global pulmonary drugs market. According to the Centers for Disease Control Prevention (CDC), over 25 million U.S. citizens have asthma. According to the same source, in 2017, around 1 in children had asthma. Moreover, according to the World Health Organization (WHO), in 2016, around 251 million cases of chronic pulmonary obstructive disease (COPD) were reported globally. Such a massive increase in respiratory diseases has increased the demand for pulmonary drugs worldwide. Pulmonary drug delivery offers numerous advantages due to the large internal surface area of the lung. Hence, such factors are expected to drive growth of the global pulmonary drugs market. Furthermore, growing emphasis on the development of smart or digital inhalers is expected to propel the global pulmonary drugs market growth in the near future.

Key competitors involved in the global pulmonary drugs market are AstraZeneca plc, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim, Sumitomo Dainippon Pharma Co., Ltd., F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals, Inc., GlaxoSmithKline plc, Pfizer Inc., Grifols, S.A., and Merck & Co., Inc.

For instance, in May 2020, AstraZeneca partnered with Propeller Health to add smart features to its Symbicort inhaler for the treatment of asthma and chronic obstructive pulmonary diseases (COPD).

Covid-19's Arrival Would Boost Adoption of Protein Assays Market for Detecting Antibodies to Coronavirus Proteins

 

The Bradford protein measure is utilized widely for investigation of proteins in numerous applications including drug revelation, sanitation, and clinical diagnostics. The measures are likewise helpful in the examination of different proteins edifices that have been recognized by different strategies. The idea of this measure depends on the connection of protein atoms with fluorescent color under acidic conditions bringing about a pale blue shading shift from blue to red. This interaction really decides the presence of the relative multitude of essential amino acids, arginine, glycine and histidine that prompts development of the co-enzymatic protein complex. It very well may be utilized in mix with different techniques for assessment of protein content.

Significant growth in the pharmaceutical sector is expected to propel growth of the global protein assays market. For instance, according to The European Federation of Pharmaceutical Industries and Associations’ Key Data 2019, the pharmaceutical sector in Europe invested US$ 19, 509 million in 2000, which increased to US$ 39,895 million (est.) in 2018. Moreover, launch of graphene-based electrochemical biosensors is also expected to aid in growth of the market. For instance, in February 2018, Nanomedical Diagnostics launched Graphene Biosensor- FLEX, which can be easily integrated with company’s Agile R100 protein assay system to increase the efficiency of the drug discovery process.

Among regions, Europe is expected to witness significant growth in the protein assays market, owing to growing pharmaceutical sector. For instance, according to The European Federation of Pharmaceutical Industries and Associations’ Key Data 2019, the pharmaceutical sector in Europe was valued at US$ 1.

Preimplantation Genetic Diagnosis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

 

Preimplantation Genetic Diagnosis is offering to help those that aren't sure if they can have children of their own or if they will suffer from certain medical issues in the future. Pregnancy and Fertility are two other reasons why this test can be offered. The procedure is done when the couple is preparing for conception by checking for any irregularities on an ultrasound. The genetic information from the unaffected parents and the affected eggs are compared to determine if a genetic problem exists with the egg of one of the partners.

The growing number of fertility clinics around the globe coupled with the advancement in the field of genetic analysis is driving the growth of preimplantation genetic Diagnosis market . The increasing need for early detection of chromosomal abnormalities in the fetus is another major factor fueling the market growth of preimplantation genetic diagnosis. The advent of next-generation sequencing (NGS) is also contributing to the market growth. Furthermore, the growing prevalence of gene-related disorders is further anticipated to augment the growth of preimplantation genetic diagnosis market. Additionally, growing awareness regarding genetic testing of a specific gene mutation among healthcare workers is again anticipated to foster market growth. Also, increasing maternal age and growing incidence of aneuploidy is expected to uplift the market growth in the near future.

From the geographical point of view, North America is expected to gain significant growth over the forecast period and this is attributed to the high incidence of the gene-related disorder in the region. According to the U.S. Department of Health and Human Services, about 1 in 200,000 people in the United States are born with syndrome A each year. Around 1 in 100,000 people in the United States have syndrome A at the present time.

Key Developments:

1. In October 2019, PerkinElmer, Inc., a global provider of innovating for a healthier world, introduced it's PG-Seq™ Rapid Non-Invasive Preimplantation Genetic diagnosis for Aneuploidy (PGT-A) kit. This solution tests spent embryo culture media for chromosomal abnormalities during in vitro fertilization (IVF) treatment.

2. In October 2018, Vitrolife AB (publ) has entered into a License and Commercialisation Agreement with Illumina, Inc., which provides Vitrolife with exclusive distribution, development, and commercialization rights to Illumina’s preimplantation genetic diagnosis business for IVF in EMEA and Americas.

3. In July 2020, Chromosome Medicina Genômica, powered by GeneOne, enter into a partnership with Genomic Prediction and Diagnostics da America (DASA), to introduce LifeView™ PGT-P to Brazil.

In 2018, over 17.7 million minimally invasive aesthetic procedures were performed in the United States, boosting the demand for powered surgical instruments market

 

In June 2019, Tata Consultancy Services, a worldwide IT administrations, counseling, and business arrangements association, has collaborated with SAP to dispatch an Intelligent Field Inventory Management (iFIM) arrangement, controlled by SAP® Leonardo, which use IoT and blockchain to help clinical gadget producers smooth out careful pack taking care of.

The expanding volume of worldwide surgeries and the rising interest for insignificantly intrusive medical procedures are driving the development of the powered surgical instruments market . American Society of Plastic Surgeons (ASPS) individuals report they performed more than 17.7 million careful and insignificantly intrusive tasteful systems in the U.S. in 2018. That is almost 277,000 more restorative strategies than in the earlier year. Expanding mechanical progression, for example, careful mechanical technology and the developing pervasiveness of the different constant sickness with the ascent in the maturing populace is additionally adding to the development of the powered surgical instruments market. Expanding worldwide medical care spending and extending clinical the travel industry are additionally expected to cultivate the development of the market.

On the other hand, inadequate quality assurance and lack of proper sterilization practices for surgical equipment are key factors expected to restrict the growth of the market.

Powered surgical instruments are used for cosmetic procedures, such as breast enhancements or liposuction, as well as for major surgeries, such as heart surgery or reconstruction of the neck or spine. The way that a surgical instrument is powered usually depends on what it is being used for, although most of them operate through some type of electrical current or gas. There are a few different ways that this can happen, depending on what the medical device is being used for. In general, the most common type of electrical current used comes from an anesthetic machine. Anesthetic machines generally contain a chamber with electrodes, where the electrocauterized gel or solution is administered, causing the body to numb its muscles. Gas-powered devices also commonly used in powered surgical instruments are nitrogen-fueled torches.

Asia Pacific region is becoming a growth hub for the powered surgical instruments market and this is due to the fact that this region is accounted for expanding medical tourism in the region. According to the India Brand Equity Foundation, the country is witnessing a 22-25 percent growth in medical tourism and healthcare providers expect the industry will double to $6 billion by 2018 from $3 billion in 2017. Medical tourists to India typically seek joint replacement surgeries, heart, liver, and bone marrow transplants, spine and brain surgeries, cancer and kidney treatments, and in vitro fertilization (IVF).

Due to a decrease in potato production, the potato processing market has experienced rapid growth

 

The most ideal approach to portray potato handling is that of an extremely cutting edge and profoundly complex assembling measure. The creation interaction includes the cutting, stripping, bubbling, broiling, drying lastly the cutting and drying of the potato skins. This is known as potato slicing and this must be done rapidly and effectively and the outcomes are basically overwhelming. The primary reason for handling is to ensure that you get the most ideal potatoes with no wastage or harm being done to the item. Aside from this the other primary design is to dispose of any extra potatoes that are found after the cycle is finished.

Market Dynamics

Government support during Covid-19 is expected to propel growth of the potato processing market. For instance, in May 2020, Canada’s Ministry of Agriculture allotted US$ 4.7 million to the P.E.I. Potato Board and Cavendish Farms, to allow millions of pounds of potatoes to be stored, amid the COVID-19 pandemic.

North America is expected to witness slight decline in growth in the potato processing market, owing to decrease in production of potatoes. For instance, according to the U.S. Department of Agriculture, potato production in the U.S. in 2019 totaled 424 million cwt, down 2 percent from the 2018 crop for comparable States.

Europe is expected to witness significant growth in the potato processing market, owing to increasing number of processing facilities. For instance, in November 2020, UK-based Branston, which supplies own-label products to supermarkets, such as Tesco, submitted plans for a new potato processing facility.

Competitive Analysis

Major players operating in the potato processing market include, Agrana Beteiligungs-AG, Agristo NV, Aviko B.V., Bem Brasil, Farm Frites International, McCain Foods USA, Idahoan Foods, Intersnack Group GmbH & Co. Kg, J.R. Simplot Company, Lamb Weston Holdings, Leng-D'or, Limagrain Céréales Ingrédients, McCain Foods Limited, and The Kraft Heinz Company.

November 2020: Bem Brasil, the largest potato processor and manufacturer of frozen French fries in Brazil ordered PEF Advantage system for potato processing suitable for processing up to 30 ton potatoes per hour from ELEA GmbH, the world leader in Pulsed Electric Field systems for food processing, has supplied a first.

September 2020: McCain Foods USA announced the restart of construction of its 170,000-square-foot expansion at its Othello, Washington potato processing facility. It was paused due to COVID-19 restrictions.

The growing need for natural gas and crude oil, the global hydrate inhibitors market is booming

 

Hydrate Inhibitors are the chemical substance which serves to regulate the rate of dissolving of monosodium hydrate in natural gas. Their function is to inhibit hydrate formation during maturation. This is a gas that is formed during the drilling process when there is the presence of water. When this occurs, it results in the production of a high amount of ethylene and propane. Due to this reason, it is essential to reduce the formation of hydrates in crude oil by using inhibitors.

There has always been a constant demand for natural gas and crude oil in the world. Hydrate inhibitors help in reducing line blockages and hydrate plugs that form during hydrate formation. Hydrate inhibitors are also utilized where other methods such as active heating and insulated flow line do not work. Owing to all these features, there is a constant demand for better inhibitors in the global hydrate inhibitors market. For instance, according to International Energy Agency, in 2019, the demand for natural gas at a worldwide level increased by 1.5% when compared to the demand of 2018. This ever-increasing demand for natural gas and crude oil is resulting in better growth of the global hydrate inhibitors market. The growth of the global hydrate inhibitors market is also dependent on the consumption of natural gas as the inhibitors are used in preventing or reducing the hydrate formation of onshore and offshore production systems.

However, low oil prices and political instability can influence the global hydrate inhibitors market negatively. According to the Organization of the Petroleum Exporting Countries (OPEC), instability in political levels has negatively impacted the production of oil and gas in Latin America's Venezuela region and has resulted in a significant decrease in the production capacity.

In recent times, there have been increased exploration activities in North America, which has resulted in the formation of significant demand in the global hydrate inhibitors market. For instance, according to Drillinginfo, there are over 900,000 active oil and gas wells in the U.S. and more than 130,000 have been drilled in the last few years. Moreover, there is a high consumption rate of natural gas in the region which is also augmenting the growth of the global hydrate inhibitors market. The hydrate inhibitors market in the Asia Pacific is witnessing exception growth in the demand curve, owing to the demand for the inhibitors from regions such as Africa and the Middle East. According to the Energy Information Administration, India has one of the largest gas reserves on its east coast. Additionally, there are increasing government initiatives related to the new development and advancement of technology of hydrate inhibitors, which is creating propulsion in the global hydrate inhibitors market.